![Michael Tomsicek](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Tomsicek
Direktör/Styrelseledamot på
MILESTONE PHARMACEUTICALS INC.
Förmögenhet: 36 773 $ per 2026-06-30
Profil
Michael John Tomsicek is currently an Independent Non-Executive Director at Milestone Pharmaceuticals, Inc. since 2019, a Director at Optimer Pharmaceuticals LLC since 2013, an Independent Director at Acrivon Therapeutics, Inc. since 2022, and a Director at Cimeio Therapeutics AG since 2022.
Former roles include Director at Trius Therapeutics, Inc., CFO, Treasurer, Principal Accounting Officer & VP at ABIOMED, Inc. from 2015 to 2017, Chief Financial Officer & Senior Vice President at Cubist Pharmaceuticals LLC from 2013 to 2015, CFO-Global Ultrasound Product Group at General Electric Healthcare Technologies, Inc. from 2009 to 2010, Chief Financial Officer at The Lexington, Manager-Commercial Finance & Business Planning at Motorola Automotive & Industrial Electronics Group, and Senior VP, Chief Financial & Accounting Officer at CRISPR Therapeutics AG from 2017 to 2021.
Education includes an undergraduate degree conferred in 1988 and an MBA conferred in 1996, both from the University of Wisconsin.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-10 | 15 001 ( 0,01 % ) | 20 101 $ | 2026-06-30 | |
| 2026-06-17 | 9 366 ( 0,02 % ) | 16 671 $ | 2026-06-30 |
Aktiva positioner av Michael Tomsicek
| Företag | Position | Start |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Direktör/Styrelseledamot | 2019-04-01 |
| ACRIVON THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2022-10-01 |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Direktör/Styrelseledamot | 2013-10-24 |
Cimeio Therapeutics AG
 Cimeio Therapeutics AG BiotechnologyHealth Technology Operates as a biotechnology company developing shielded-cell & immunotherapy pairs, which protect genetically modified cells from targeted therapies | Direktör/Styrelseledamot | 2022-11-03 |
Tidigare kända positioner av Michael Tomsicek
| Företag | Position | Slut |
|---|---|---|
| CRISPR THERAPEUTICS AG | Finansdirektör/CFO | 2021-10-14 |
| ABIOMED, INC. | Finansdirektör/CFO | 2017-08-24 |
| CUBIST PHARMACEUTICALS INC | Finansdirektör/CFO | 2015-01-01 |
General Electric Healthcare Technologies, Inc.
 General Electric Healthcare Technologies, Inc. Medical/Nursing ServicesHealth Services Provides transformational medical technologies and services | Företagsledare/Principal | 2010-09-01 |
The Lexington
 The Lexington Medical/Nursing ServicesHealth Services Operates a 125-bed assisted living facility | Finansdirektör/CFO | - |
Michael Tomsiceks utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
88
Första gradens relationer
12
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 12 |
|---|---|
ABIOMED, Inc.
 ABIOMED, Inc. Medical SpecialtiesHealth Technology Manufactures cardiac support, recovery and replacement devices | Health Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Milestone Pharmaceuticals, Inc.
 Milestone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cardiovascular medicines | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Health Technology |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
General Electric Healthcare Technologies, Inc.
General Electric Healthcare Technologies, Inc. Medical/Nursing ServicesHealth Services Provides transformational medical technologies and services | Health Services |
The Lexington
The Lexington Medical/Nursing ServicesHealth Services Operates a 125-bed assisted living facility | Health Services |
Motorola Automotive & Industrial Electronics Group | |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Acrivon Therapeutics, Inc.
 Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
Cimeio Therapeutics AG
Cimeio Therapeutics AG BiotechnologyHealth Technology Operates as a biotechnology company developing shielded-cell & immunotherapy pairs, which protect genetically modified cells from targeted therapies | Health Technology |
